Cleiton de Castro Marques

BIOLAB is a Brazilian pharmaceutical corporation which develops, manufactures and commercializes medicines. BIOLAB is proud to be a benchmark in health products innovation. BIOLAB's core business is to produce prescription medicines in cardiology, rheumatology, orthopedics, general practice, pediatrics, endocrinology, geriatrics and dermatology. Following a global trend, they are massively investing in dermocosmetics, developing products to meet the requirements of the country's different weather characteristics, the different types of skin, and the use of natural resources from its biodiversity. BIOLAB is a leader in cardiovascular product prescriptions and ranks 8th in prescription drug sales. BIOLAB carries in its DNA the vocation for research, as a fundamental way for the development of new products and technologies. Since the company was founded, investment in research has allowed the launch of four exclusive products.

BIOLAB is a Brazilian pharmaceutical corporation which develops, manufactures and commercializes medicines. BIOLAB is proud to be a benchmark in health products innovation. BIOLAB's core business is to produce prescription medicines in cardiology, rheumatology, orthopedics, general practice, pediatrics, endocrinology, geriatrics and dermatology. Following a global trend, they are massively investing in dermocosmetics, developing products to meet the requirements of the country's different weather characteristics, the different types of skin, and the use of natural resources from its biodiversity. BIOLAB is a leader in cardiovascular product prescriptions and ranks 8th in prescription drug sales. BIOLAB carries in its DNA the vocation for research, as a fundamental way for the development of new products and technologies. Since the company was founded, investment in research has allowed the launch of four exclusive products.

BIOLAB is a Brazilian pharmaceutical corporation which develops, manufactures and commercializes medicines. BIOLAB is proud to be a benchmark in health products innovation. BIOLAB's core business is to produce prescription medicines in cardiology, rheumatology, orthopedics, general practice, pediatrics, endocrinology, geriatrics and dermatology. Following a global trend, they are massively investing in dermocosmetics, developing products to meet the requirements of the country's different weather characteristics, the different types of skin, and the use of natural resources from its biodiversity. BIOLAB is a leader in cardiovascular product prescriptions and ranks 8th in prescription drug sales. BIOLAB carries in its DNA the vocation for research, as a fundamental way for the development of new products and technologies. Since the company was founded, investment in research has allowed the launch of four exclusive products.

BIOLAB is a Brazilian pharmaceutical corporation which develops, manufactures and commercializes medicines. BIOLAB is proud to be a benchmark in health products innovation. BIOLAB's core business is to produce prescription medicines in cardiology, rheumatology, orthopedics, general practice, pediatrics, endocrinology, geriatrics and dermatology. Following a global trend, they are massively investing in dermocosmetics, developing products to meet the requirements of the country's different weather characteristics, the different types of skin, and the use of natural resources from its biodiversity. BIOLAB is a leader in cardiovascular product prescriptions and ranks 8th in prescription drug sales. BIOLAB carries in its DNA the vocation for research, as a fundamental way for the development of new products and technologies. Since the company was founded, investment in research has allowed the launch of four exclusive products.